Literature DB >> 2180999

Characterization of the dermal infiltrates in Jessner's lymphocytic infiltrate of the skin, polymorphous light eruption and cutaneous lupus erythematosus: differential diagnostic and pathogenetic aspects.

J U Rijlaarsdam1, C Nieboer, E de Vries, R Willemze.   

Abstract

In the present study a comparative immunohistochemical study was performed on skin biopsies from of patients with Jessner's lymphocytic infiltration of the skin (LIS), polymorphous light eruption (PLE), discoid lupus erythematosus (DLE) and subacute cutaneous lupus erythematosus (SCLE) using a large panel of monoclonal antibodies against T cell differentiation antigens (CD3, CD4, CD8), immunoregulatory T cell subsets (CD7, 4B4, 2H4, Leu 8), B cells (CD22), activated cells CD25, OKT9, HLA-DR), Langerhans cells (CD1) and macrophages (Leu-M5). The results showed many similarities between LIS and PLE. The most important differences between these conditions and CDLE/SCLE were the high proportions of cells reactive with monoclonal antibody Leu-8 and the absence of T cells expressing HLA-DR antigens in LIS and PLE, suggesting absence of local T cell activation in these conditions. The differential diagnostic and pathogenetic aspects of these findings will be discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180999     DOI: 10.1111/j.1600-0560.1990.tb01670.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sjögren syndrome: 7-year follow-up and immunohistochemical study.

Authors:  Yasuhiro Horiuchi; Junichi Hakugawa; Kazuhiro Shimizu; Ichiro Katayama; Tomayoshi Hayashi; Masahiro Kikuchi
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

2.  Coexistence of tumid lupus erythematosus with systemic lupus erythematosus and discoid lupus erythematosus: a report of two cases of tumid lupus.

Authors:  Jennifer Stead; Catherine Headley; Michael Ioffreda; Carrie Kovarik; Victoria Werth
Journal:  J Clin Rheumatol       Date:  2008-12       Impact factor: 3.517

3.  Serum Transforming Growth Factor-Beta 1 Level in Egyptian Systemic Lupus Erythematosus Patients.

Authors:  Manal El Menyawi; Mary Fawzy; Mohamed Habib; Olfat Shaker
Journal:  Arch Rheumatol       Date:  2018-07-31       Impact factor: 1.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.